Adaptimmune Therapeutics (ADAP)
NASDAQ: ADAP
· Real-Time Price · USD
0.28
-0.00 (-1.06%)
At close: Jun 09, 2025, 3:58 PM
13F Institute Ownership
Total Institutes of 82 in Adaptimmune Therapeutics expanded their positions with an increase of 0 investors compared to the previous quarter. A reduction of 27.27M shares, as total invested capital declined by $77.12M with ownership percentage dropping from 9.88% to 8.11%.
Options Activity
Institutions are holding more Calls Contracts as Puts Contracts, indicating a bullish sentiment.
Put/Call 0.477
0.48
Call Flow 34,200
68%
Put Flow 16,300
32%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Ecor1 Capital, LLC | 1.79% | 27.4M | +0.00% | 14.76M | 0.56% |
| Long Focus Capital Management,... | 1.34% | 20.49M | +54.09% | 11.04M | 0.36% |
| Nea Management Company, LLC | 1.11% | 17.08M | +0.00% | 9.2M | 0.52% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.